Laine K, Raasakka T, Mäntynen J, Saukko P
Department of Pharmacology and Clinical Pharmacology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.
Headache. 1999 Jul-Aug;39(7):511-2. doi: 10.1046/j.1526-4610.1999.3907511.x.
Typically, 3% to 5% of patients experience sensations of heaviness, pressure, and tightness in the chest after administration of sumatriptan, but there is little ECG evidence of ischemia. The serious cardiovascular incidents after consuming sumatriptan have been associated mostly with the subcutaneous dosage form of this drug and with patients with underlying cardiovascular risk factors. We report a case of fatal cardiac arrhythmia in an otherwise perfectly healthy patient with migraine after consuming a single 100-mg dose of oral sumatriptan.
通常,3%至5%的患者在服用舒马曲坦后会出现胸部沉重、压迫和紧绷感,但几乎没有心电图显示缺血的证据。服用舒马曲坦后的严重心血管事件大多与该药物的皮下剂型以及有潜在心血管危险因素的患者有关。我们报告一例原本完全健康的偏头痛患者,在服用单次100毫克口服舒马曲坦后发生致命性心律失常的病例。